Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Drug Administration of Vietnam fines Domesco 145 million VND over circulation and unauthorized drug distribution

08/06/2026 Published by Pharma Biz

The Drug Administration of Vietnam, operating under the Ministry of Health, has officially issued an administrative sanction decree targeting Domesco... Read more

Tags: #Vietnam

Drug Administration of Vietnam fines Agimexpharm 160 million VND over circulation and distribution violations

08/06/2026 Published by Pharma Biz

The Drug Administration of Vietnam, operating under the Ministry of Health, has officially issued an administrative sanction decree targeting Agimexpharm... Read more

Category: Uncategorized

Tags: #Vietnam

Vietnam Food Administration requests e-commerce platforms to remove and halt sales of recalled Australian food products

08/06/2026 Published by Pharma Biz

The Vietnam Food Administration (VFA), operating under the Ministry of Health, has officially dispatched formal directives to the Agency for... Read more

Category: Uncategorized

Tags: #Vietnam

Ministry of Health mandates implementation of Circular 06/2026/TT-BYT on ICD-10 disease coding to standardize medical data and preserve insurance benefits

08/06/2026 Published by Pharma Biz

Permanent Deputy Minister of Health Vu Manh Ha has officially signed an executive directive driving the rapid implementation of Circular... Read more

Category: Uncategorized

Tags: #Vietnam

FV Hospital generates nearly 1,000 billion VND for Thomson Medical Group; Drives National Health Insurance integration to expand patient base

05/06/2026 Published by ViNe

Vietnam has rapidly emerged as a core market for Singapore-based Thomson Medical Group (TMG) following its milestone acquisition of FV... Read more

Category: Uncategorized

Tags: #Vietnam

J&J’s nipocalimab hits primary endpoint in Phase II JASMINE study for systemic lupus erythematosus

05/06/2026 Published by ViNe

Johnson & Johnson (J&J) has reported that its investigational monoclonal antibody, nipocalimab, successfully met its primary clinical endpoint in the... Read more

Category: Uncategorized

Tags: #Global Trends

US Court rules Abbott Laboratories must face class-action lawsuit over PediaSure height growth claims

05/06/2026 Published by ViNe

A U.S. federal judge in Manhattan has ruled that Abbott Laboratories must defend itself against a proposed class-action lawsuit. The... Read more

Category: Uncategorized

Alnylam enters $2 billion strategic generative AI collaboration with Inceptive to accelerate RNAi drug discovery

05/06/2026 Published by ViNe

Alnylam Pharmaceuticals has entered into a definitive strategic collaboration with Inceptive to integrate generative artificial intelligence (AI) directly into its... Read more

Category: Uncategorized